Profil
David Kinniburgh has been Vice President of Laboratory Operations for Isotechnika, Inc. since January 2004.
Dr. Kinniburgh joined Isotechnika as Senior Director of Diagnostics Development and Analytical Services in 2002.
He received an MS in 1977 and a PhD in 1981 from the University of Calgary.
Anciens postes connus de David Kinniburgh
| Sociétés | Poste | Fin |
|---|---|---|
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Corporate Officer/Principal | - |
Formation de David Kinniburgh
| University of Calgary | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Health Technology |
